Advertise | Contact

Home
News
Features
Biomarkers
Events
eBooks
Whitepapers
Webinars
Jobs
Marketplace

Search:

Most Popular Stories

Most Read
Most Emailed
Latest News

FDA maps out long-awaited rules for the biosimilars business
FDA approvals of 2011
Mouse study triggers demands for a possible Alzheimer's treatment
High price of failure drives drug development costs into the stratosphere
Eisai loses panel vote on new Dacogen use
GSK, Takeda say nay to in-house diagnostics units

FDA approvals of 2011
13 Big Pharmas to collaborate on $785M fight against neglected diseases
The 25 most influential people in biopharma today
New death reports prompt EMA review of Gilenya

Eisai loses panel vote on new Dacogen use
Mouse study triggers demands for a possible Alzheimer's treatment
NeurogesX slammed again as FDA panel spurns pain patch
High price of failure drives drug development costs into the stratosphere
FDA maps out long-awaited rules for the biosimilars business

Webinars

Getting the most out of First-in-Human and Early Clinical Trials
In a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
Webinar: Next Gen Sequencing from FFPE Samples
Next generation sequencing (NGS) technologies hold enormous promise to advance personalize
Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected Devices
After launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
Active Directory & the Cloud for Biotech & Pharma
Biotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webi

More Webinars >>

Hottest Products

Compare Top Solutions in:

Clinical Trial Management Software (CTMS)
Clinical Data Management Systems (CDMS)
Phase I Clinical Studies
Phase II Clinical Studies
Clinical Research Organizations (CRO)
Clinical Trial Monitoring

Evaluate more than 400,000 products >>

Featured Jobs

Associate Manager, Global Supply Chain Planning (1 of 3) Job
Celgene Corporation - Basking Ridge, NJ, US
Docket Clerk Job
Celgene Corporation - Summit, NJ, US
Product Manager, Channel Marketing Job
Celgene Corporation - Summit, NJ, US
Clinical Research Associate
Jennerex, Inc - San Francisco, CA
Benefits Specialist Job
Celgene Corporation - Summit, NJ, US

Popular Topics

FDA
Biotech Venture Capital
Phase III
biopharmaceutical company
GlaxoSmithKline
Pfizer
Phase II

biotechnology company
pharmaceuticals
Merck
Mergers and Acquisitions
Novartis
Clinical Trial
Biotech deals

Events

Live Web Conference: Risk Management of Adventitious Agent Contamination
March 21
Pharmaceutical Strategic Outlook
April 11-13, 2012
DCAT Week 2012
Mar 12-15 — New York City
BioNetwork East: Key BioPharma Partnering Conference
March 5-7 2012 — Miami, Florida

Free Newsletter

Free Daily FierceBiotech Newsletter: About | View Sample | Privacy

FEATURES >> 15 Top Blockbuster Contenders | 10 Promising Therapeutic Vaccines

Merck CEO Richard Clark

November 12, 2006 — 1:01pm ET

Free newsletter via e-mail

Tools

Subscribe
Email
Print
Contact Author
Reprint

Merck CEO Richard Clark

SHARE
WITH:

Get Your FREE FierceBiotech Email Newsletter:

Home | Subscribe | Advertise | Mobile Edition | RSS | Privacy | Site Map | Editors | List in Marketplace | Supplier in Marketplace

THE FIERCEMARKETS NETWORK

FierceEnergy | FierceSmartGrid | FierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceHealthPayer | FiercePracticeManagement | FierceEMR | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceGovernment | FierceHomelandSecurity | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceMedicalDevices | FierceDrugDelivery | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceEnterpriseCommunications | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe | FierceCable

© 2011 FierceMarkets. All rights reserved.